Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-023499
Filing Date
2025-08-13
Accepted
2025-08-13 16:20:53
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 448495
2 EX-5.1 ex5-1.htm EX-5.1 15423
3 EX-10.3 ex10-3.htm EX-10.3 98006
4 EX-23.2 ex23-2.htm EX-23.2 6214
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 26599
6 GRAPHIC forms-3_001.jpg GRAPHIC 3411
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2548
8 GRAPHIC ex23-2_001.jpg GRAPHIC 5155
9 GRAPHIC ex23-2_002.jpg GRAPHIC 32081
  Complete submission text file 0001641172-25-023499.txt   779426

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5623
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289576 | Film No.: 251211976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)